litlas
Log inCreate account

Irving Kirsch

Active 1982–2025

115
Papers
23,140
Citations
85
h-index
111
i10-index

Citations

Citations per year for Irving Kirsch1952: 1 citations1958: 1 citations1978: 1 citations1983: 1 citations1985: 1 citations1986: 2 citations1987: 2 citations1988: 2 citations1989: 3 citations1990: 5 citations1991: 6 citations1992: 4 citations1993: 2 citations1994: 10 citations1995: 13 citations1996: 4 citations1997: 28 citations1998: 12 citations1999: 45 citations2000: 23 citations2001: 40 citations2002: 42 citations2003: 55 citations2004: 78 citations2005: 132 citations2006: 110 citations2007: 99 citations2008: 135 citations2009: 193 citations2010: 205 citations2011: 188 citations2012: 191 citations2013: 203 citations2014: 253 citations2015: 234 citations2016: 169 citations2017: 242 citations2018: 201 citations2019: 635 citations2020: 549 citations2021: 520 citations2022: 443 citations2023: 304 citations2024: 445 citations2025: 171 citations2026: 6 citations1953–1957: no citations, so these years are not shown1959–1977: no citations, so these years are not shown1979–1982: no citations, so these years are not shown1984: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,679 citing papers, 27.7% of this breakdownUnited Kingdom: 675 citing papers, 11.1% of this breakdownGermany: 468 citing papers, 7.7% of this breakdownCanada: 331 citing papers, 5.5% of this breakdownAustralia: 273 citing papers, 4.5% of this breakdownChina: 269 citing papers, 4.4% of this breakdownItaly: 263 citing papers, 4.3% of this breakdownNetherlands: 263 citing papers, 4.3% of this breakdownSwitzerland: 156 citing papers, 2.6% of this breakdownSweden: 137 citing papers, 2.3% of this breakdownBelgium: 129 citing papers, 2.1% of this breakdownDenmark: 126 citing papers, 2.1% of this breakdown
0%27.7%Other 21.4%

Institutions

Fields

  • Medicine38.5%
  • Neuroscience36.6%
  • Psychology14.7%
  • Computer Science2%
  • Health Professions1.6%
  • Biochemistry, Genetics and Molecular Biology1.5%
  • Other5.1%

Topics

  • Pain Management and Placebo Effect11.9%
  • Pain Mechanisms and Treatments4.5%
  • Treatment of Major Depression4.3%
  • Acupuncture Treatment Research Studies3.1%
  • Musculoskeletal pain and rehabilitation2.7%
  • Psychosomatic Disorders and Their Treatments2.4%
  • Other71.1%

Coauthors

All papers

Open in search
  1. Implications of Placebo and Nocebo Effects for Clinical Practice: Expert Consensus

    Authors: Andrea W.M. Evers, Luana Colloca, Charlotte Blease, Marco Annoni, Lauren Y. Atlas, Fabrizio Benedetti, Ulrike Bingel, Christian Büchel, Cláudia Carvalho, Ben Colagiuri, Alia J. Crum, Paul Enck, Jens Gaab, Andrew L. Geers, Jeremy Howick, Karin Jensen, Irving Kirsch, Karin Meißner, Vitaly Napadow, Kaya J. Peerdeman, Amir Raz, Winfried Rief, Lene Vase, Tor D. Wager, Bruce E. Wampold, Katja Weimer, Katja Wiech, Ted J. Kaptchuk, Regine Klinger, John M. Kelley - Psychotherapy and Psychosomatics 2018 cited by 565

  2. Efficacy and Safety of Selective Serotonin Reuptake Inhibitors, Serotonin-Norepinephrine Reuptake Inhibitors, and Placebo for Common Psychiatric Disorders Among Children and Adolescents

    Authors: Cosima Locher, Helen Koechlin, Sean R. Zion, Christoph Werner, Daniel S. Pine, Irving Kirsch, Ronald C. Kessler, Joe Kossowsky - JAMA Psychiatry 2017 cited by 352

  3. Meta-analysis of neural systems underlying placebo analgesia from individual participant fMRI data

    Authors: Matthias Zunhammer, Tamás Spisák, Tor D. Wager, Ulrike Bingel, Lauren Y. Atlas, Fabrizio De Benedetti, Christian Büchel, Jae Chan Choi, Luana Colloca, Davide Duzzi, Falk Eippert, Dan‐Mikael Ellingsen, Sigrid Elsenbruch, Stephan Geuter, Ted J. Kaptchuk, Simon S. Kessner, Irving Kirsch, Jian Kong, Claus Lamm, Siri Leknes, Fausta Lui, Alexa Huber, Carlo Adolfo Porro, Markus Rütgen, Lieven A. Schenk, Julia Schmid, Nina Theysohn, Irene Tracey, Nathalie Wrobel, Fadel Zeidan - Nature Communications 2021 cited by 174

  4. Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug Administration

    Authors: Irving Kirsch, Brett J. Deacon, Tania B. Huedo–Medina, Alan Scoboria, Thomas J. Moore, Blair T. Johnson - PLoS Medicine 2008 cited by 2,441

  5. Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome

    Authors: Ted J. Kaptchuk, John M. Kelley, Lisa Conboy, Roger B. Davis, Catherine E. Kerr, Eric Jacobson, Irving Kirsch, Rosa N. Schyner, Bong Hyun Nam, Long Thành Nguyễn, Min Park, Andrea L. Rivers, Claire McManus, Efi Kokkotou, Douglas A. Drossman, Peter Goldman, Anthony Lembo - BMJ 2008 cited by 1,199

  6. Blinding in randomised clinical trials of psychological interventions: a retrospective study of published trial reports

    Authors: Sophie Juul, Christian Gluud, Sebastian Simonsen, Frederik Weischer Frandsen, Irving Kirsch, Janus Christian Jakobsen - BMJ evidence-based medicine 2020 cited by 152

  7. Response to acute monotherapy for major depressive disorder in randomized, placebo controlled trials submitted to the US Food and Drug Administration: individual participant data analysis

    Authors: Marc B. Stone, Zimri S. Yaseen, Brian J. Miller, Kyle Richardville, Shamir N. Kalaria, Irving Kirsch - BMJ 2022 cited by 117

  8. What are the treatment remission, response and extent of improvement rates after up to four trials of antidepressant therapies in real-world depressed patients? A reanalysis of the STAR*D study’s patient-level data with fidelity to the original research protocol

    Authors: H. Edmund Pigott, Thomas T. Kim, Colin Xu, Irving Kirsch, Jay D. Amsterdam - BMJ Open 2023 cited by 76

  9. Placebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome

    Authors: Ted J. Kaptchuk, Elizabeth Friedlander, John M. Kelley, M. Norma Sanchez, Efi Kokkotou, Joyce P. Singer, Magda Kowalczykowski, Franklin G. Miller, Irving Kirsch, Anthony Lembo - PLoS ONE 2010 cited by 912

  10. Sham device v inert pill: randomised controlled trial of two placebo treatments

    Authors: Ted J. Kaptchuk, William B. Stason, Roger B. Davis, Anna R. T. Legedza, Rosa N. Schnyer, Catherine E. Kerr, David A. Stone, Bong Hyun Nam, Irving Kirsch, Rose H. Goldman - BMJ 2006 cited by 528

  11. Placebo Effect in the Treatment of Depression and Anxiety

    Authors: Irving Kirsch - Frontiers in Psychiatry 2019 cited by 204

  12. Patient Expectancy as a Mediator of Placebo Effects in Antidepressant Clinical Trials

    Authors: Bret R. Rutherford, Melanie M. Wall, Patrick J. Brown, Tse‐Hwei Choo, Tor D. Wager, Bradley S. Peterson, Sarah H. Chung, Irving Kirsch, Steven P. Roose - American Journal of Psychiatry 2016 cited by 166

  13. Should antidepressants be used for major depressive disorder?

    Authors: Janus Christian Jakobsen, Christian Gluud, Irving Kirsch - BMJ evidence-based medicine 2019 cited by 164

  14. Brain-to-brain mechanisms underlying pain empathy and social modulation of pain in the patient-clinician interaction

    Authors: Dan‐Mikael Ellingsen, Kylie Isenburg, Chang Jin Jung, Jeungchan Lee, Jessica Gerber, Ishtiaq Mawla, Roberta Sclocco, Arvina Grahl, Alessandra Anzolin, Robert R. Edwards, John M. Kelley, Irving Kirsch, Ted J. Kaptchuk, Vitaly Napadow - National Academy of Sciences, Proceedings of the National Academy of Sciences 2023 cited by 48

  15. Default mode network connectivity encodes clinical pain: An arterial spin labeling study

    Authors: Marco L. Loggia, Jieun Kim, Randy L. Gollub, Márk Vangel, Irving Kirsch, Jian Kong, Ajay D. Wasan, Vitaly Napadow - Pain 2012 cited by 317

  16. Open-label placebo treatment in chronic low back pain: a randomized controlled trial

    Authors: Cláudia Carvalho, Joaquim Machado Caetano, Lidia Cunha, Paula Rebouta, Ted J. Kaptchuk, Irving Kirsch - Pain 2016 cited by 416

  17. Altered Placebo and Drug Labeling Changes the Outcome of Episodic Migraine Attacks

    Authors: Slavenka Kam‐Hansen, Moshe Jakubowski, John M. Kelley, Irving Kirsch, David C. Hoaglin, Ted J. Kaptchuk, Rami Burstein - Science Translational Medicine 2014 cited by 394

  18. What Should Clinicians Tell Patients about Placebo and Nocebo Effects? Practical Considerations Based on Expert Consensus

    Authors: Andrea W.M. Evers, Luana Colloca, Charlotte Blease, Jens Gaab, Karin Jensen, Lauren Y. Atlas, Chris Beedie, Fabrizio Benedetti, Ulrike Bingel, Christian Büchel, Jet Bussemaker, Ben Colagiuri, Alia J. Crum, Damien G. Finniss, Andrew L. Geers, Jeremy Howick, Regine Klinger, Stefanie H. Meeuwis, Karin Meißner, Vitaly Napadow, Keith J. Petrie, Winfried Rief, Ionica Smeets, Tor D. Wager, Vishvarani Wanigasekera, Lene Vase, John M. Kelley, Irving Kirsch - Psychotherapy and Psychosomatics 2020 cited by 96

  19. Brain Activity Associated with Expectancy-Enhanced Placebo Analgesia as Measured by Functional Magnetic Resonance Imaging

    Authors: Jian Kong, Randy L. Gollub, Ilana S. Rosman, Julia Megan Webb, Márk Vangel, Irving Kirsch, Ted J. Kaptchuk - Journal of Neuroscience 2006 cited by 397

  20. Response Expectancy and the Placebo Effect

    Authors: Irving Kirsch - International review of neurobiology 2018 cited by 133

  21. Open-label placebo vs double-blind placebo for irritable bowel syndrome: a randomized clinical trial

    Authors: Anthony Lembo, John M. Kelley, Judy Nee, Sarah Ballou, Johanna Iturrino, Vivian Cheng, Vikram Rangan, Jesse Katon, William Hirsch, Irving Kirsch, Kathryn T. Hall, Roger B. Davis, Ted J. Kaptchuk - Pain 2021 cited by 98

  22. Dynamic brain-to-brain concordance and behavioral mirroring as a mechanism of the patient-clinician interaction

    Authors: Dan‐Mikael Ellingsen, Kylie Isenburg, Chang Jin Jung, Jeungchan Lee, Jessica Gerber, Ishtiaq Mawla, Roberta Sclocco, Karin Jensen, Robert R. Edwards, John M. Kelley, Irving Kirsch, Ted J. Kaptchuk, Vitaly Napadow - Science Advances 2020 cited by 88

  23. Imaginative suggestibility and hypnotizability: An empirical analysis.

    Authors: Wayne Braffman, Irving Kirsch - Journal of Personality and Social Psychology 1999 cited by 256

  24. Is the rationale more important than deception? A randomized controlled trial of open-label placebo analgesia

    Authors: Cosima Locher, Antje Frey Nascimento, Irving Kirsch, Joe Kossowsky, Andrea H. Meyer, Jens Gaab - Pain 2017 cited by 189